+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 127 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124497
UP TO OFF until Dec 31st 2022
The United States Specialty Drug Distribution Market size was estimated at USD 340.41 million in 2021, USD 386.97 million in 2022, and is projected to grow at a CAGR 13.99% to reach USD 747.03 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Specialty Drug Distribution to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Indication, the market was studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.
  • Based on Type, the market was studied across Full line Wholesalers and Specialty Distributors.
  • Based on Distribution Type, the market was studied across Clinic/ASCs, Home Health, Inpatient, Mail Delivery, Outpatient, and Retail.
  • Based on Distribution Channel, the market was studied across Hospitals & Care Providers, Independent Pharmacies, Large Chain Pharmacies, Online Stores, and Specialty Pharmacies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Specialty Drug Distribution market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Drug Distribution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Specialty Drug Distribution Market, including Anda, Inc., Avella Specialty Pharmacy, Biologics, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company, Greenhill & Co., Inc., and Pfizer Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Specialty Drug Distribution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Specialty Drug Distribution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Specialty Drug Distribution Market?
4. What is the competitive strategic window for opportunities in the United States Specialty Drug Distribution Market?
5. What are the technology trends and regulatory frameworks in the United States Specialty Drug Distribution Market?
6. What is the market share of the leading vendors in the United States Specialty Drug Distribution Market?
7. What modes and strategic moves are considered suitable for entering the United States Specialty Drug Distribution Market?
Frequently Asked Questions about the U.S. Specialty Drug Distribution Market

What is the estimated value of the U.S. Specialty Drug Distribution Market?

The U.S. Specialty Drug Distribution Market was estimated to be valued at $340.41 Million in 2021.

What is the growth rate of the U.S. Specialty Drug Distribution Market?

The growth rate of the U.S. Specialty Drug Distribution Market is 13.9%, with an estimated value of $747.03 Million by 2027.

What is the forecasted size of the U.S. Specialty Drug Distribution Market?

The U.S. Specialty Drug Distribution Market is estimated to be worth $747.03 Million by 2027.

Who are the key companies in the U.S. Specialty Drug Distribution Market?

Key companies in the U.S. Specialty Drug Distribution Market include Anda, Inc., Avella Specialty Pharmacy, Biologics, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company and Pfizer Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Specialty Drug Distribution Market, by Indication
6.1. Introduction
6.2. Aids
6.3. Hemophilia
6.4. Multiple Sclerosis
6.5. Oncology
6.6. Rheumatoid Arthritis
7. Specialty Drug Distribution Market, by Type
7.1. Introduction
7.2. Full Line Wholesalers
7.3. Specialty Distributors
8. Specialty Drug Distribution Market, by Distribution Type
8.1. Introduction
8.2. Clinic/Ascs
8.3. Home Health
8.4. Inpatient
8.5. Mail Delivery
8.6. Outpatient
8.7. Retail
9. Specialty Drug Distribution Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Independent Pharmacies
9.4. Large Chain Pharmacies
9.5. Online Stores
9.6. Specialty Pharmacies
10. California Specialty Drug Distribution Market11. Florida Specialty Drug Distribution Market12. Illinois Specialty Drug Distribution Market13. New York Specialty Drug Distribution Market14. Ohio Specialty Drug Distribution Market15. Pennsylvania Specialty Drug Distribution Market16. Texas Specialty Drug Distribution Market
17. Competitive Landscape
17.1. Fpnv Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, by Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Anda, Inc.
18.2. Avella Specialty Pharmacy
18.3. Biologics, Inc.
18.4. Curascript, Inc.
18.5. Cvs Health Corporation
18.6. Diplomat Pharmacy, Inc.
18.7. Express Scripts Holding Company
18.8. Greenhill & Co., Inc.
18.9. Pfizer Inc.
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
FIGURE 8. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2027
FIGURE 11. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 22. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2027
FIGURE 24. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2021 VS 2027 (%)
FIGURE 29. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2027
FIGURE 31. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, 2019-2027 (USD MILLION)
FIGURE 36. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, 2019-2027 (USD MILLION)
FIGURE 38. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 39. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 44. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 46. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2019-2027 (USD MILLION)
FIGURE 47. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 52. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, 2019-2027 (USD MILLION)
FIGURE 53. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 54. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 55. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 56. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 64. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 29. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 30. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 32. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 34. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 35. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 37. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 39. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 40. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 41. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 42. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 44. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 45. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 46. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 47. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 49. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 50. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 51. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 52. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 54. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 57. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 59. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 60. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2019-2027 (USD MILLION)
TABLE 61. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 63. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 64. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 65. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET RANKING
TABLE 66. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 67. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET MERGER & ACQUISITION
TABLE 68. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 69. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 70. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET INVESTMENT & FUNDING
TABLE 71. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 72. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: LICENSE & PRICING

Companies Mentioned

  • Anda, Inc.
  • Avella Specialty Pharmacy
  • Biologics, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Express Scripts Holding Company
  • Greenhill & Co., Inc.
  • Pfizer Inc.

Methodology

Loading
LOADING...